Overview

Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients

Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The study will be conducted to investigate the pharmacokinetics of ampicillin / sulbactam and amoxicillin/clavulanic acid during intermittent haemodialysis.
Phase:
Phase 3
Details
Lead Sponsor:
Medical University of Vienna
Treatments:
Amoxicillin
Ampicillin
Clavulanic Acid
Clavulanic Acids
Sulbactam
Sultamicillin